JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.30 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $703,000 | +2.8% | 15,377 | +0.8% | 0.01% | +16.7% |
Q3 2017 | $684,000 | +64.4% | 15,254 | +9.5% | 0.01% | +50.0% |
Q2 2017 | $416,000 | -29.7% | 13,926 | -47.8% | 0.00% | -20.0% |
Q1 2017 | $592,000 | -59.6% | 26,689 | -65.7% | 0.01% | -58.3% |
Q4 2016 | $1,465,000 | +85.7% | 77,716 | +195.7% | 0.01% | +50.0% |
Q3 2016 | $789,000 | +415.7% | 26,282 | +560.7% | 0.01% | +700.0% |
Q2 2016 | $153,000 | -53.8% | 3,978 | -36.0% | 0.00% | -50.0% |
Q2 2015 | $331,000 | – | 6,214 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 1,864,174 | $85,211,000 | 94.86% |
Crestline Management, LP | 7,631,631 | $348,841,000 | 35.74% |
Omega Fund Management, LLC | 753,564 | $34,445,000 | 24.90% |
DDD Partners, LLC | 191,458 | $8,752,000 | 3.40% |
SIB LLC | 100,000 | $4,571,000 | 3.28% |
PECONIC PARTNERS LLC | 433,587 | $19,819,000 | 2.85% |
Cormorant Asset Management, LP | 550,000 | $25,141,000 | 2.63% |
ARK Investment Management | 682,495 | $31,197,000 | 2.48% |
BB BIOTECH AG | 1,925,000 | $87,992,000 | 2.48% |
Clarius Group, LLC | 120,988 | $5,530,000 | 2.47% |